Solid oral dosage forms of valsartan
May 7, 2019. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 3200039 Divisible tablet having controlled and delayed release of the active substance Process for the preparation of sustained release pharmaceutical compositions having a high active ingredient content Pharmaceutical products of moxonidine and hydrochlorothiazide Acyl compounds Method of modifying ovarian hormone-regulated AT1 receptor activity as treatment of incapacitating symptom(s) of P.M.S. Readily available konjac glucomannan as a sustained release excipient Fast dissolving tablet and its production Pharmaceutical granulate Pharmaceutical compositions containing irbesartan Patent #: 5994348 InventorsAssigneeApplicationNo. 202805 filed on 05/07/1999US Classes:424/465, With claimed perfecting feature in contents (e.g., excipient, lubricant, etc.)424/464, Tablets, lozenges, or pills424/489, Particulate form (e.g., powders, granules, beads, microcapsules, and pellets)514/222.8, Polycyclo ring system having the six-membered hetero ring as one of the cyclos514/223.2, 1,2,4 - Benzothiadiazine - 1,1 - dioxides (including hydrogenated)514/223.5With additional active ingredientExaminersPrimary: Page, Thurman K.Assistant: Di Nola-Baron, Liliana Attorney, Agent or FirmForeign Patent References
International ClassA61K 009/20Foreign Application Priority Data1996-06-27 GBAbstractThe present invention is concerned with solid dosage forms comprising a) valsartan and optionally HCTZ, and b) pharmaceutically acceptable additives suitable for the preparation of solid oral dosage forms by compression methods.Other References
Field of SearchWith claimed perfecting feature in contents (e.g., excipient, lubricant, etc.)Tablets, lozenges, or pills Containing polysaccharide (e.g., sugar, etc.) Particulate form (e.g., powders, granules, beads, microcapsules, and pellets) Heterocyclic monomer Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) With additional active ingredient | |
